A function blocking anti-mouse integrin alpha5beta1 antibody inhibits angiogenesis and impedes tumor growth in vivo.

A function blocking anti-mouse integrin alpha5beta1 antibody inhibits angiogenesis and impedes tumor growth in vivo. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

A function blocking anti-mouse integrin alpha5beta1 antibody inhibits angiogenesis and impedes tumor growth in vivo. Abstract Text:

Vinay Bhaskar,Dong Zhang,Melvin Fox,Pui Seto,Melanie H L Wong,Pauline E Wales,David Powers,Debra T Chao,Robert B Dubridge,Vanitha Ramakrishnan,Vinay Bhaskar,Dong Zhang,Melvin Fox,Pui Seto,Melanie H L Wong,Pauline E Wales,David Powers,Debra T Chao,Robert B Dubridge,Vanitha Ramakrishnan,

BACKGROUND: Integrins are important adhesion molecules that regulate tumor and endothelial cell survival, proliferation and migration. The integrin alpha5beta1 has been shown to play a critical role during angiogenesis. An inhibitor of this integrin, volociximab (M200), inhibits endothelial cell growth and movement in vitro, independent of the growth factor milieu, and inhibits tumor growth in vivo in the rabbit VX2 carcinoma model. Although volociximab has already been tested in open label, pilot phase II clinical trials in melanoma, pancreatic and renal cell cancer, evaluation of the mechanism of action of volociximab has been limited because this antibody does not cross-react with murine alpha5beta1, precluding its use in standard mouse xenograft models. METHODS: We generated a panel of rat-anti-mouse alpha5beta1 antibodies, with the intent of identifying an antibody that recapitulated the properties of volociximab. Hybridoma clones were screened for analogous function to volociximab, including specificity for alpha5beta1 heterodimer and blocking of integrin binding to fibronectin. A subset of antibodies that met these criteria were further characterized for their capacities to bind to mouse endothelial cells, inhibit cell migration and block angiogenesis in vitro. One antibody that encompassed all of these attributes, 339.1, was selected from this panel and tested in xenograft models. RESULTS: A panel of antibodies was characterized for specificity and potency. The affinity of antibody 339.1 for mouse integrin alpha5beta1 was determined to be 0.59 nM, as measured by BIAcore. This antibody does not significantly cross-react with human integrin, however 339.1 inhibits murine endothelial cell migration and tube formation and elicits cell death in these cells (EC50 = 5.3 nM). In multiple xenograft models, 339.1 inhibited the growth of established tumors by 40-60% (p < 0.05) and this inhibition correlates with a concomitant decrease in vessel density. CONCLUSION: The results herein demonstrate that 339.1, like volociximab, exhibits potent anti-alpha5beta1 activity and confirms that inhibition of integrin alpha5beta1 impedes angiogenesis and slows tumor growth in vivo.

A function blocking anti-mouse integrin alpha5beta1 antibody inhibits angiogenesis and impedes tumor growth in vivo. Publishing Authors By Initials

V Bhaskar,D Zhang,M Fox,P Seto,MH Wong,PE Wales,D Powers,DT Chao,RB Dubridge,V Ramakrishnan,V Bhaskar,D Zhang,M Fox,P Seto,MH Wong,PE Wales,D Powers,DT Chao,RB Dubridge,V Ramakrishnan,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

A function blocking anti-mouse integrin alpha5beta1 antibody inhibits angiogenesis and impedes tumor growth in vivo. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Journal of translational medicine

VOLUME: 5

Page Numbers: 61

Journal Abbreviation:

ISSN: 1479-5876

DAY: 27

MONTH: 11

YEAR: 2007

A function blocking anti-mouse integrin alpha5beta1 antibody inhibits angiogenesis and impedes tumor growth in vivo. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 101190741

A function blocking anti-mouse integrin alpha5beta1 antibody inhibits angiogenesis and impedes tumor growth in vivo. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: A function blocking anti-mouse integrin alpha5beta1 antibody inhibits angiogenesis and impedes tumor growth in vivo. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for A function blocking anti-mouse integrin alpha5beta1 antibody inhibits angiogenesis and impedes tumor growth in vivo.

AFFILIATION: Department of Research, PDL Biopharma, Inc,, Fremont, CA 94555, USA. vinay.bhaskar@pdl.com

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Transl Med

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

A function blocking anti-mouse integrin alpha5beta1 antibody inhibits angiogenesis and impedes tumor growth in vivo Related Publications

• "The very pulse of the machine": the tuberculous granuloma in motion.
• A function blocking anti-mouse integrin alpha5beta1 antibody inhibits angiogenesis and impedes tumor growth in vivo.
• Acute medical assessment units.
• Alternative equations for whole-body protein synthesis and for fractional synthetic rates of proteins.
• An unusual case of fibromatosis of the axilla.
• Binding of endostatin to human ovarian cancer cells inhibits cell attachment.
• CMGSDB: integrating heterogeneous Caenorhabditis elegans data sources using compositional data mining.
• Detection of obstructive respiratory abnormality using flow-volume spirometry and radial basis function neural networks.
• Dichotomous role of the macrophage in early Mycobacterium marinum infection of the zebrafish.
• Elevated high sensitivity CRP levels in patients with mitral stenosis and left atrial thrombus.
• Endostatin binding to ovarian cancer cells inhibits peritoneal attachment and dissemination.
• Hyalinizing clear cell carcinoma of the base of tongue.
• Kringle 5 of human plasminogen, an angiogenesis inhibitor, induces both autophagy and apoptotic death in endothelial cells.
• Letter to the Glyco-Forum: catalytic domains of glycosyltransferases with 'add-on' domains.
• Mechanism for expanding the decoding capacity of transfer RNAs by modification of uridines.
• Modulation of angiogenic phenotype alters tumorigenicity in rat ovarian epithelial cells.
• Multiplex fluorescent in situ hybridization in zebrafish embryos using tyramide signal amplification.
• Performance of a hybrid MC dose algorithm for IMRT optimization dose evaluation.
• SVD-based modeling for image texture classification using wavelet transformation.
• Salvage of a DIEP flap using a retrograde flow anastomosis.
• Secondary glaucomas: the tasks ahead.
• Solvatochromic study of 1,2-dihydroxyanthraquinone in neat and binary solvent mixtures.
• Strongly Correlated Superconductivity in Rh17S15.
• Structures of tRNAs with an expanded anticodon loop in the decoding center of the 30S ribosomal subunit.
• Studying apolipoprotein turnover with stable isotope tracers: correct analysis is by modeling enrichments.
• The eukaryotic translation initiation factors eIF1 and eIF1A induce an open conformation of the 40S ribosome.
• The termination of translation.
• Volociximab, a chimeric integrin alpha5beta1 antibody, inhibits the growth of VX2 tumors in rabbits.
• Voronoi networks and their probability of misclassification.
• Why is long-term therapy required to cure tuberculosis?